Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston.
Department of Surgery, Baylor College of Medicine, Houston, Texas.
JAMA Surg. 2023 Nov 1;158(11):1195-1202. doi: 10.1001/jamasurg.2023.4221.
Circumferential resection margin (CRM) in rectal cancer surgery is a major prognostic indicator associated with local recurrence and overall survival. Facility rates of CRM positivity have recently been established as a new quality measure by the Commission on Cancer (CoC); however, the completeness of CRM status reporting is not well characterized.
To describe the changes in CRM reporting and factors associated with low rates of reporting.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was conducted using data from the National Cancer Database between January 2010 and December 2019. Data were analyzed between October 1, 2021, and February 1, 2022. Data from the National Cancer Database included patients diagnosed with nonmetastatic rectal adenocarcinoma receiving surgical treatment at CoC-accredited facilities throughout the US.
Patient, tumor, and facility-level factors. Facilities were divided by surgical volume, safety-net status, and CoC facility type.
Circumferential resection margin missingness rates.
A total of 110 571 patients (59.3% men) with rectal adenocarcinoma who underwent curative-intent surgery at 1307 CoC-accredited hospitals were included for analysis. Reporting of CRM improved over the study period, with a mean (SE) missing 12.0% (0.32%) decreased from 16.3% (0.36%). Academic facilities had a higher missingness than other facility types (14.3% vs 10.5%-12.7%; P < .001). Mean (SE) rates of missingness were similar between hospitals of varying volume (lowest quartile: 12.2% [0.93%] vs highest quartile: 12.4% [0.53%]; P = .96). Cases in which fewer than 12 lymph nodes were removed had higher rates of missingness (18.1% vs 11.4%; P < .001). Increased odds of CRM missingness were noted with T category (odds ratio [OR], 1.50; 95% CI, 1.35-1.65) and N category (OR, 2.00; 95% CI, 1.82-2.20). Black race was associated with missingness (OR, 1.13; 95% CI, 1.06-1.14).
Although CRM positivity reporting has improved over the last decade, the findings of this study suggest there is substantial room for improvement as it becomes a quality standard. Missingness appears to be associated with poor performance on other quality metrics and facility type. This measure appears to be ideal for targeted institution-level feedback to improve quality of care nationally.
直肠癌手术中的环周切缘(CRM)是与局部复发和总生存相关的主要预后指标。最近,癌症委员会(CoC)将 CRM 阳性率作为新的质量衡量标准;然而,CRM 状态报告的完整性尚未得到很好的描述。
描述 CRM 报告的变化情况,并确定与低报告率相关的因素。
设计、地点和参与者:这是一项使用 2010 年 1 月至 2019 年 12 月期间国家癌症数据库的数据进行的回顾性队列研究。数据分析于 2021 年 10 月 1 日至 2022 年 2 月 1 日之间进行。国家癌症数据库的数据包括在美国 CoC 认证机构接受手术治疗的非转移性直肠腺癌患者。
患者、肿瘤和机构水平因素。根据手术量、安全网地位和 CoC 机构类型对机构进行了划分。
环周切缘缺失率。
共有 110571 名(59.3%为男性)接受 CoC 认证机构根治性手术治疗的直肠腺癌患者被纳入分析。在研究期间,CRM 报告有所改善,缺失率从 16.3%(0.36%)平均(SE)降低 12.0%(0.32%)。学术机构的缺失率高于其他机构类型(14.3%比 10.5%-12.7%;P<.001)。不同手术量的医院之间缺失率相似(最低四分位数:12.2%[0.93%]与最高四分位数:12.4%[0.53%];P=.96)。淋巴结切除数少于 12 枚的病例缺失率较高(18.1%比 11.4%;P<.001)。T 分期(比值比[OR],1.50;95%CI,1.35-1.65)和 N 分期(OR,2.00;95%CI,1.82-2.20)与 CRM 缺失率相关。黑种人种族与缺失率相关(OR,1.13;95%CI,1.06-1.14)。
尽管过去十年中 CRM 阳性报告有所改善,但本研究结果表明,随着该报告成为质量标准,仍有很大的改进空间。缺失率似乎与其他质量指标和机构类型的不良表现有关。该指标似乎非常适合针对特定机构进行反馈,以提高全国的护理质量。